Urinary and blood cadmium and lead and kidney function: NHANES 2007-2012

International Journal of Hygiene and Environmental Health

Volumn 219, Issue 3, 2016, Pages 261-267

  Buser, Melanie C ^a   Ingber, Susan Z ^a   Raines, Nathan ^a   Fowler, David A ^a   Scinicariello, Franco ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

Albuminuria; Blood cadmium; Blood lead; Estimated glomerular filtration rate; Urinary cadmium; Urinary lead

Indexed keywords

CADMIUM; LEAD; POLLUTANT;

ADULT; ALBUMINURIA; BLOOD; ENVIRONMENTAL MONITORING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; MALE; NUTRITION; PHYSIOLOGY; POLLUTANT; UNITED STATES; URINE;

ADULT; ALBUMINURIA; CADMIUM; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LEAD; MALE; NUTRITION SURVEYS; UNITED STATES;

EID: 84960494768     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2016.01.005     Document Type: Article

References (37)

1. ATSDR Agency for Toxic Substances and Disease Registry. Toxicological Profile for Lead 2007, US Department of Health and Human Services, Public Health Service, Atlanta, GA.
2. ATSDR Agency for toxic substances and disease registry. Draft Toxicological Profile for Cadmium 2012, US Department of Health and Human Services, Public Health Service, Atlanta, GA.
3. Akerstrom M., Sallsten G., Lundhh T., Barregard L. Associations between urinary excretion of cadmium and proteins in a nonsmoking population: renal toxicity or normal physiology?. Environ. Health Perspec. 2013, 121:187-191.
4. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ. Health Perspect. 2005, 113(12):1669-1674.
5. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113(2):192-200.
6. Baumgarten M., Gehr T. Chronic kidney disease: detection and evaluation. Am. Fam. Physician. 2011, 84:1138-1148.
7. Bernard A. Cadmium and its adverse effects on human health. Indian J. Med. Res. 2008, 128:557-564.
8. Chaumont A., Nickmilder M., Dumont X., Lundh T., Skerfving S., Bernard A. Associations between proteins and heavy metals in urine at low environmental exposures: evidence of reverse causality. Toxicol. Lett. 2012, 210:345-352.
9. Collins A.J., Foley R.N., Herzog C., Chavers B., Gilbertson D., Herzog C., Ishani A., et al. US renal data system 2012 annual data report. Am. J. Kidney Dis. 2013, 61(1 Suppl. 1):A7.
10. Diamond G.L. Risk assessment of nephrotoxic metals. The Toxicology of the Kidney 2005, 1099-1132. CRC Press, London. J. Tarloff, L. Lash (Eds.).
11. Evans M., Elinder C.-G. Chronic renal failure from lead: myth or evidence-based fact?. Kidney Int. 2011, 79:272-279.
12. Fadrowski J.J., Navas-Acien A., Tellez-Plaza M., Guallar E., Weaver V.M., Furth S.L. Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2010, 170:75-82.
13. Ferraro P.M., Costanz S., Naticchia A., Sturniolo A., Gambaro G. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Pub. Health 2010, 10:304-311.
14. Franchini I., Alinovi R., Bergamaschi E., Mutti A. Contribution of studies on renal effects of heavy metals and selected organic compounds to our understanding of the progression of chronic nephropathies towards renal failure. Acta Biomed. 2005, 76(Suppl. 2):58-67.
15. Gingsberg G. Cadmium risk assessment in relation to background risk of chronic kidney disease. J. Toxicol. Environ. Health A 2012, 75:374-390.
16. Haddam N., Samira S., Dumont X., Taleb A., Lison D., Haufroid V., et al. Confounders in the assessment of the renal effects associated with low-level urinary cadmium: an analysis in industrial workers. Environ. Health 2011, 10:37-45.
17. Ikeda M., Ezaki T., Tsukahara T., Moriguchi J., Furuki K., Fukui Y., et al. Bias induced by the use of creatinine-corrected values in evaluation of beta2-microgloblin levels. Toxicol. Lett. 2003, 145(2):197-207.
18. Järup L., Berglund M., Elinder C.G., Nordberg G., Vahter M. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand. J. Work Environ. Health 1998, 1:1-51.
19. Kalil-Manesh F., Gonick H.C., Cohen A.H., Alinovi R., Bergamaschi E., Mutti A., Rosen V.J. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int. 1992, 41:1192-1203.
20. Khalil-Manesh F., Gonick H.C., Cohen A.H. Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch. Environ. Health: An. Int. J. 1993, 48:271-278.
21. Kim R., Rotnitsky A., Sparrow D., Weiss S., Wager C., Hu H. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA 1996, 275:1177-1181.
22. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med. 2003, 139:137-147.
23. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612.
24. McCarley P.B., Burrows-Hudson S. Chronic kidney disease and cardiovascular disease-using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease. Nephrol. Nurs. J. 2006, 33:666-674.
25. Muntner P., He J., Vupputuri S., Coresh J., Batuman V. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int. 2003, 63:1044-1050.
26. National Health and Nutrition Examination Survey Home Page 2008, NCHS. National Center for Health Statistics, Centers for Disease Control and Prevention, National Center for Health Statistics, Atlanta, GA, 〈http://www.cdc.gov/nchs/nhanes.htm〉 (Accessed December 2013).
27. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999-2010 2013, NCHS. National Center for Health Statistics, Centers for Disease Control and Prevention, National Center for Health Statistics, Atlanta, GA, 〈http://www.cdc.gov/nchs/data/series/sr_02/sr02_161.pdf〉 (Accessed December 2013).
28. National Health and Nutrition Examination Survey: Analytic Guidelines, 2011-2012 2013, NCHS. National Center for Health Statistics, Centers for Disease Control and Prevention, National Center for Health Statistics, Atlanta, GA, 〈http://www.cdc.gov/nchs/data/nhanes/analytic_guidelines_11_12.pdf〉 (Accessed December 2013).
29. Navas-Acien A., Tellez-Plaza M., Guallar E., Muntner P., Silbergeld E., Jaar B., Weaver V. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am. J. Epidemiol. 2009, 170:1156-1164.
30. OSHA.Occupational Safety and Health Administration Substance Safety Data Sheet-Cadmium-Standard Number 1910.1027 App A. 57 FR 42389, Sept. 14, 1992, as amended at 58 FR 21781, Apr. 23, 1993 1993, United States Department of Labor. Regulations (Standards-29 CFR), https://www.osha.gov/pls/oshaweb/owadisp.show_document%3Fp_id=10036%26p_table=STANDARDS (Accessed January 2014).
31. Soderland P., Lovekar S., Weiner D.E., Brooks D.R., Kaufman J.S. Chronic kidney disease associated with environmental toxins and exposures. Adv. Chronic Kidney Dis. 2010, 17:254-264.
32. Staessen J.A., Lauwerys R.R., Buchet J.P., Bulpitt C.J., Rondia D., Vanrenterghem Y., Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. The cadmibel study group. N. Engl. J. Med. 1992, 327:151-156.
33. Staessen J., Yeoman W.B., Fletcher A.E., Markowe H.L., Marmot M.G., Rose G., Semmence A., Shipley M.J., Bulpitt C.J. Blood lead concentration, renal function, and blood pressure in London civil servants. Br. J. Ind. Med. 1990, 47:442-447.
34. Weaver V.M., Kim N.S., Jaar B.G., Schwartz B.S., Parsons P.K., Steuerwald A.J., et al. Associations of low-level urine cadmium with kidney function in lead workers. Occup. Environ. Med. 2011, 68:250-256.
35. Weaver V.M., Kim N.S., Lee B.K., Parsons P.J., Spector J., Fadrowski J., et al. Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ. Res. 2011, 111:1236-1242.
36. Yu C.-C., Lin J.-L., Lin-Tan D.-T. Environmental Exposure to Lead and Progression of Chronic Renal Diseases: A Four-Year Prospective Longitudinal Study. J. Am. Soc. Nephrol. 2004, 15:1016-1022.
37. Zhang Q.L., Rothenbacker D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008, 8:117.